Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up
Papp, K.A., Griffiths, C.E.M., Gordon, K., Lebwohl, M., Szapary, P.O., Wasfi, Y., Chan, D., Hsu, M.-C., Ho, V., Ghislain, P.D., Strober, B., Reich, K.
Published in British journal of dermatology (1951) (01.04.2013)
Published in British journal of dermatology (1951) (01.04.2013)
Get full text
Journal Article
European S3-Guidelines on the systemic treatment of psoriasis vulgaris - Update 2015 - Short version - EDF in cooperation with EADV and IPC
Nast, A., Gisondi, P., Ormerod, A.D., Saiag, P., Smith, C., Spuls, P.I., Arenberger, P., Bachelez, H., Barker, J., Dauden, E., de Jong, E.M., Feist, E., Jacobs, A., Jobling, R., Kemény, L., Maccarone, M., Mrowietz, U., Papp, K.A., Paul, C., Reich, K., Rosumeck, S., Talme, T., Thio, H.B., van de Kerkhof, P., Werner, R.N., Yawalkar, N.
Published in Journal of the European Academy of Dermatology and Venereology (01.12.2015)
Published in Journal of the European Academy of Dermatology and Venereology (01.12.2015)
Get full text
Journal Article
Topical tofacitinib for atopic dermatitis: a phase IIa randomized trial
Bissonnette, R., Papp, K.A., Poulin, Y., Gooderham, M., Raman, M., Mallbris, L., Wang, C., Purohit, V., Mamolo, C., Papacharalambous, J., Ports, W.C.
Published in British journal of dermatology (1951) (01.11.2016)
Published in British journal of dermatology (1951) (01.11.2016)
Get full text
Journal Article
Efficacy and safety of tofacitinib, an oral Janus kinase inhibitor, in the treatment of psoriasis: a Phase 2b randomized placebo-controlled dose-ranging study
Papp, K.A., Menter, A., Strober, B., Langley, R.G., Buonanno, M., Wolk, R., Gupta, P., Krishnaswami, S., Tan, H., Harness, J.A.
Published in British journal of dermatology (1951) (01.09.2012)
Published in British journal of dermatology (1951) (01.09.2012)
Get full text
Journal Article
Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled phase II dose-ranging study
Papp, K.A., Langley, R.G., Sigurgeirsson, B., Abe, M., Baker, D.R., Konno, P., Haemmerle, S., Thurston, H.J., Papavassilis, C., Richards, H.B.
Published in British journal of dermatology (1951) (01.02.2013)
Published in British journal of dermatology (1951) (01.02.2013)
Get full text
Journal Article
A prospective phase III, randomized, double-blind, placebo-controlled study of brodalumab in patients with moderate-to-severe plaque psoriasis
Papp, K.A., Reich, K., Paul, C., Blauvelt, A., Baran, W., Bolduc, C., Toth, D., Langley, R.G., Cather, J., Gottlieb, A.B., Thaçi, D., Krueger, J.G., Russell, C.B., Milmont, C.E., Li, J., Klekotka, P.A., Kricorian, G., Nirula, A.
Published in British journal of dermatology (1951) (01.08.2016)
Published in British journal of dermatology (1951) (01.08.2016)
Get full text
Journal Article
A randomized phase 2b trial of baricitinib, an oral Janus kinase (JAK) 1/JAK2 inhibitor, in patients with moderate-to-severe psoriasis
Papp, K.A., Menter, M.A., Raman, M., Disch, D., Schlichting, D.E., Gaich, C., Macias, W., Zhang, X., Janes, J.M.
Published in British journal of dermatology (1951) (01.06.2016)
Published in British journal of dermatology (1951) (01.06.2016)
Get full text
Journal Article
AURIEL‐PsO: a randomized, double‐blind phase III equivalence trial to demonstrate the clinical similarity of the proposed biosimilar MSB11022 to reference adalimumab in patients with moderate‐to‐severe chronic plaque‐type psoriasis
Hercogová, J., Papp, K.A., Chyrok, V., Ullmann, M., Vlachos, P., Edwards, C.J.
Published in British journal of dermatology (1951) (01.02.2020)
Published in British journal of dermatology (1951) (01.02.2020)
Get full text
Journal Article
Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: results from two randomized, placebo-controlled, phase III trials
Papp, K.A., Menter, M.A., Abe, M., Elewski, B., Feldman, S.R., Gottlieb, A.B., Langley, R., Luger, T., Thaci, D., Buonanno, M., Gupta, P., Proulx, J., Lan, S., Wolk, R.
Published in British journal of dermatology (1951) (01.10.2015)
Published in British journal of dermatology (1951) (01.10.2015)
Get full text
Journal Article
A randomized, double-blind, placebo-controlled study to evaluate the addition of methotrexate to etanercept in patients with moderate to severe plaque psoriasis
Gottlieb, A.B., Langley, R.G., Strober, B.E., Papp, K.A., Klekotka, P., Creamer, K., Thompson, E.H.Z., Hooper, M., Kricorian, G.
Published in British journal of dermatology (1951) (01.09.2012)
Published in British journal of dermatology (1951) (01.09.2012)
Get full text
Journal Article
Long-term efficacy of ustekinumab in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trial through up to 3 years
Kimball, A.B., Gordon, K.B., Fakharzadeh, S., Yeilding, N., Szapary, P.O., Schenkel, B., Guzzo, C., Li, S., Papp, K.A.
Published in British journal of dermatology (1951) (01.04.2012)
Published in British journal of dermatology (1951) (01.04.2012)
Get full text
Journal Article
Long‐term safety of risankizumab from 17 clinical trials in patients with moderate‐to‐severe plaque psoriasis
Gordon, K.B., Lebwohl, M., Papp, K.A., Bachelez, H., Wu, J.J., Langley, R.G., Blauvelt, A., Kaplan, B., Shah, M., Zhao, Y., Sinvhal, R., Reich, K.
Published in British journal of dermatology (1951) (01.03.2022)
Published in British journal of dermatology (1951) (01.03.2022)
Get full text
Journal Article
Long‐term efficacy and safety of risankizumab for the treatment of moderate‐to‐severe plaque psoriasis: interim analysis of the LIMMitless open‐label extension trial beyond 3 years of follow‐up
Papp, K.A., Lebwohl, M.G., Puig, L., Ohtsuki, M., Beissert, S., Zeng, J., Rubant, S., Sinvhal, R., Zhao, Y., Soliman, A.M., Alperovich, G., Leonardi, C.
Published in British journal of dermatology (1951) (01.12.2021)
Published in British journal of dermatology (1951) (01.12.2021)
Get full text
Journal Article
Efficacy and safety of apremilast in subjects with moderate to severe plaque psoriasis: results from a phase II, multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison study
Papp, K.A., Kaufmann, R., Thaçi, D., Hu, C., Sutherland, D., Rohane, P.
Published in Journal of the European Academy of Dermatology and Venereology (01.03.2013)
Published in Journal of the European Academy of Dermatology and Venereology (01.03.2013)
Get full text
Journal Article
Impact of previous biologic use on the efficacy and safety of brodalumab and ustekinumab in patients with moderate‐to‐severe plaque psoriasis: integrated analysis of the randomized controlled trials AMAGINE‐2 and AMAGINE‐3
Papp, K.A., Gordon, K.B., Langley, R.G., Lebwohl, M.G., Gottlieb, A.B., Rastogi, S., Pillai, R., Israel, R.J.
Published in British journal of dermatology (1951) (01.08.2018)
Published in British journal of dermatology (1951) (01.08.2018)
Get full text
Journal Article
Safety of guselkumab in patients with moderate‐to‐severe psoriasis treated through 100 weeks: a pooled analysis from the randomized VOYAGE 1 and VOYAGE 2 studies
Reich, K., Papp, K.A., Armstrong, A.W., Wasfi, Y., Li, S., Shen, Y.K., Randazzo, B., Song, M., Kimball, A.B.
Published in British journal of dermatology (1951) (01.05.2019)
Published in British journal of dermatology (1951) (01.05.2019)
Get full text
Journal Article
Ixekizumab treatment for psoriasis: integrated efficacy analysis of three double‐blinded, controlled studies (UNCOVER‐1, UNCOVER‐2, UNCOVER‐3)
Papp, K.A., Leonardi, C.L., Blauvelt, A., Reich, K., Korman, N.J., Ohtsuki, M., Paul, C., Ball, S., Cameron, G.S., Erickson, J., Zhang, L., Mallbris, L., Griffiths, C.E.M.
Published in British journal of dermatology (1951) (01.03.2018)
Published in British journal of dermatology (1951) (01.03.2018)
Get full text
Journal Article
Safety of tildrakizumab for moderate‐to‐severe plaque psoriasis: pooled analysis of three randomized controlled trials
Blauvelt, A., Reich, K., Papp, K.A., Kimball, A.B., Gooderham, M., Tyring, S.K., Sinclair, R., Thaçi, D., Li, Q., Cichanowitz, N., Green, S., La Rosa, C.
Published in British journal of dermatology (1951) (01.09.2018)
Published in British journal of dermatology (1951) (01.09.2018)
Get full text
Journal Article
European S3‐Guideline on the systemic treatment of psoriasis vulgaris – Update Apremilast and Secukinumab – EDF in cooperation with EADV and IPC
Nast, A., Spuls, P.I., Kraaij, G., Gisondi, P., Paul, C., Ormerod, A.D., Saiag, P., Smith, C.H., Dauden, E., Jong, E.M., Feist, E., Jobling, R., Maccarone, M., Mrowietz, U., Papp, K.A., Reich, K., Rosumeck, S., Talme, T., Thio, H.B., Kerkhof, P., Werner, R.N., Dressler, C.
Published in Journal of the European Academy of Dermatology and Venereology (01.12.2017)
Published in Journal of the European Academy of Dermatology and Venereology (01.12.2017)
Get full text
Journal Article
Sustained efficacy of secukinumab in patients with moderate‐to‐severe palmoplantar psoriasis: 2·5‐year results from GESTURE, a randomized, double‐blind, placebo‐controlled trial
Gottlieb, A.B., Kubanov, A., Doorn, M., Sullivan, J., Papp, K.A., You, R., Regnault, P., Frueh, J.A.
Published in British journal of dermatology (1951) (01.04.2020)
Published in British journal of dermatology (1951) (01.04.2020)
Get full text
Journal Article